Synspira Therapeutics Headquarters
Looking for information about Synspira Therapeutics Headquarters? The links below have collected all the necessary data.
https://www.synspira.com/
A Chance to Inspire For the people living with Progressive Pulmonary Diseases like bronchiectasis and Malabsorption Syndromes such as exocrine pancreatic insufficiency (EPI), a significant unmet medical need exists. Synspira aims to change the course of their disease by developing and commercializing novel treatments. LEARN MORE
https://www.synspira.com/contact/
Contact Us. Synspira Therapeutics Inc. 10 Speen Street Framingham MA 01701 (617) 466-3111. General Inquiries. [email protected]
https://www.crunchbase.com/organization/synspira
Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2017. Founders Shenda Baker. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email [email protected]. Phone Number (781) 235-3060. Synspira Therapeutics is focused on developing a rationally designed portfolio of ...Founded: 2017
https://www.zoominfo.com/c/synspira-therapeutics-inc/416871590
Synspira Therapeutics’s headquarters are in 10 Speen St, Framingham, Massachusetts, 01701, United States. What is Synspira Therapeutics’s phone number? Synspira Therapeutics’s phone number is (617) 466-3111.Employees: 26
https://www.massbio.org/members/synspira-therapeutics/
Synspira Therapeutics is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis and other rare diseases where there is a high unmet treatment need. Synspira is a privately held company headquartered in Framingham, MA. Our lead product, SNSP-113, is a first-of-its-kind product with a broad spectrum mechanism of action […]
https://craft.co/synspira
Oct 20, 2020 · Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases such as primary ciliary dyskinesia and bronchiectasis. It develops SNSP113, an inhaled non-absorbed glycopolymer therapeutics. Show moreEmployees: 19
https://www.linkedin.com/company/synspira
Synspira Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF) and other rare diseases. Inspired by ...
https://pitchbook.com/profiles/company/182665-36
Sep 14, 2017 · Synspira Therapeutics General Information Description. Developer of glycopolymer-based therapeutics designed for the treatment of pulmonary diseases. The company's therapeutics are intended to treat and to alter the progression of pulmonary diseases by disrupting mucus accumulation and bacterial bio-film invasion as well as malabsorption syndromes and exocrine pancreatic …
https://www.synspira.com/about/leadership/
Prior to joining Synspira, Mr. Gallotto was the co-founder and served as President of Alcresta Therapeutics, a company focused on developing products for cystic fibrosis and other rare diseases. Mr. Gallotto built the company from an idea to the successful launch of its first product, RELiZORB, a novel medical device awarded the 2016 Medical ...
Have you found Synspira Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|